Author: Bongers Mathilda L.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.30, Iss.1, 2012-01, pp. : 17-34
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Lewis G Peake M Aultman R Gyldmark M Morlotti L Creeden J de la Orden M
The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. :
Afatinib for the treatment of advanced non-small-cell lung cancer
By Genova Carlo Rijavec Erika Barletta Giulia Burrafato Giovanni Biello Federica Dal Bello Maria Giovanna Coco Simona Truini Anna Alama Angela Boccardo Francesco Grossi Francesco
Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 6, 2014-04 ,pp. :
Vandetanib for the treatment of non-small-cell lung cancer
By Wong Hui-li de Boer Richard H
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. :